pharma news today glp-1 obesity drug Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine WHO GLP-1 Treatments: WHO Endorses

It is still unclear whether the effect of GLP-1RAs is a result of the direct activation of the hepatic GLP-1 receptor, or an indirect effect caused by weight loss, glycemic control, changes in lipoprotein metabolism, or improved insulin sensitivity [15,34]

Rather than following traditional dosing protocols, patients and physicians are exploring whether smaller amounts can still provide meaningful benefits while minimizing potential side effects

Reconstitution math for DIY researchers If you are reconstituting semaglutide from lyophilized powder, you have the unique advantage of choosing your concentration

Weight Loss Injections in NYC Unlock your weight loss potential with GLP-1 therapy

In the years since so-called weight-loss jabs entered widespread use, there have been reports that these drugs may not just reduce food cravings, but in fact cravings and desires full-stop

Recently, the dual GIP/GLP-1 receptor agonist tirzepatide achieved greater body weight reduction than SEMA (at a dose of 1 mg) in patients with T2D [119, 120]